NCT04177862View on ClinicalTrials.gov

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
PainPain, AcuteAnesthesia
Interventions
DRUG

Sublingual Sufentanil

30 mcg of sublingual sufentanil

DRUG

IV Fentanyl

50 mcg of IV fentanyl

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT04177862 - Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center | Biotech Hunter | Biotech Hunter